药物受理最新动态：Merck Healthcare Germany GmbH富马酸比索洛尔片进...

Core Viewpoint - The application for Fumaric Acid Bisoprolol Tablets by Merck Healthcare Germany GmbH has been accepted by the National Medical Products Administration of China, indicating a significant step in the drug's market entry process [1] Group 1: Application Details - The application acceptance date is December 13, 2025 [1] - The application number for the drug is JYHZ2500291 [1] - The drug type is classified as a chemical drug and the application type is for import re-registration [1] Group 2: Company Information - The applicant company is Merck Healthcare Germany GmbH, which is part of the larger Merck Group, including Merck Healthcare KGaA and Merck Serono Co. Ltd. [1]